Concentrix Corporation (FRA:CO8)

Market Cap	2.86B
Revenue (ttm)	8.48B
Net Income (ttm)	206.45M
Shares Out	n/a
EPS (ttm)	3.22
PE Ratio	13.87
Forward PE	4.33
Dividend	1.20 (2.45%)
Ex-Dividend Date	Jul 25, 2025

Volume	100
Average Volume	70
Open	49.40
Previous Close	50.50
Day's Range	49.20 - 49.40
52-Week Range	34.20 - 68.00
Beta	n/a
RSI	47.36
Earnings Date	Sep 24, 2025

About Intra-Cellular Therapies

Concentrix Corporation designs, builds, and runs integrated customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics, and business transformation services to clients in various industry verticals comprising technology and consumer electronics; retail, travel, and e-commerce; communications and media; banking, financial services, and insurance; and healthcare. It also offers customer lifecycle management; CX/user experien...

• Industry: Computer Processing and Data Preparation and Processing Services
• Founded: 2004
• Employees: 450,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CO8

Financial Performance

In 2024, Concentrix's revenue was $9.62 billion, an increase of 35.20% compared to the previous year's $7.11 billion. Earnings were $241.71 million, a decrease of -21.48%.